DJ Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bristol Myers Squibb Co. $(BMY)$ slipped 3.19% to $64.69 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.58% to 7,673.52 and Dow Jones Industrial Average falling 1.18% to 52,786.07.

This was the stock's second consecutive day of losses.

Bristol Myers Squibb Co. closed 5.75% short of its 52-week high of $68.64, which the company reached on August 19th.

The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 2.22% to $269.12, Pfizer Inc. $(PFE)$ fell 2.32% to $27.79, and Abbott Laboratories $(ABT)$ fell 2.59% to $105.52.

Trading volume (9.5 M) remained 1.3 million below its 50-day average volume of 10.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.